Search Results - "Kalemkerian, G.P"

Risk Factors for Noncancer Progression–Associated Death in Patients With Non-Small Cell Lung Cancer by Kong, F.M, Campbell, J, Jin, J.Y, Jolly, S, Owen, D, Wang, W, Kalemkerian, G.P, Lawrence, T.S

Get full text

A Phase II Trial of Midtreatment PET-CT Adapted Radiation Therapy With Concurrent Chemotherapy in Patients With Inoperable/Unresectable Non-Small Cell Lung Cancer (NSCLC) by Kong, F.M, Ten Haken, R.K, Schipper, M, Hayman, J, Ramnath, N, Hassan, K, Matuszak, M.M, Ritter, T, Bi, N, Wang, W, Orringer, M, Cease, K, Lawrence, T.S, Kalemkerian, G.P

Get full text

Predictors of Acute Esophagitis in Lung Cancer Patients Treated With Definitive Radiation Therapy by Hobson, S, Abugharib, A, Schipper, M, Matuszak, M.M, Owen, D, Hayman, J.A, Kalemkerian, G.P, Ten Haken, R.K, Kong, F.M, Lawrence, T.S, Jolly, S

Get full text

Lower Incidence of Esophagitis in the Elderly Undergoing Definitive Radiation Therapy for Lung Cancer by Soni, P.D, Boonstra, P.S, Schipper, M, Bazzi, L, Dess, R.T, Matuszak, M.M, Kong, F.M, Hayman, J.A, Haken, R. K. Ten, Lawrence, T.S, Kalemkerian, G.P, Jolly, S

Get full text

A Phase 2 Trial of Midtreatment FDG-PET Adaptive, Individualized Radiation Therapy Plus Concurrent Chemotherapy in Patients With Non-Small Cell Lung Cancer (NSCLC) by Kong, F.P, Ten Haken, R.K, Schipper, M, Hayman, J, Ramnath, N, Hassan, K, Ritter, T, Cease, K, Lawrence, T.S, Kalemkerian, G.P

Get full text

Personalized High Dose Radiation (>70 Gy) Is Significantly Associated with Better Local Regional Control and Overall Survival in Non-small Cell Lung Cancer Treated with Concurrent Chemoradiation by Kong, F.P, Ten Haken, R, Hayman, J, Ramnath, N, Hassan, K, Wang, J, Cease, K, Orringer, M, Kalemkerian, G.P, Lawrence, T.S

Get full text

Predictors of Radiation-Induced Esophagitis in the Treatment of Lung Cancer: An Analysis of Inflammatory Cytokine Levels and Dosimetric Parameters by Hunter, K.U, Wang, L, Schipper, M, Xu, L, Hayman, J.A, Ten Haken, R, Cease, K, Kalemkerian, G.P, Kong, F

Get full text

The Value of Single Nucleotide Polymorphisms in TGFβ1, TPA and ACE in Survival Prediction in Patients with Non-small Cell Lung Cancer by Xie, C, Yuan, S, Ellingrod, V.L, Hayman, J.A, Arenberg, D, Curtis, J, Ramath, N, Kalemkerian, G.P, Wang, J, Kong, F

Get full text

PCN121 ONCOLOGY MEDICATION UTILIZATION BASED ON FEDERAL DRUG ADMINISTRATION (FDA) LABELING, NATIONAL COMPREHENSIVE CANCER NETWORK (NCCN) CLINICAL PRACTICE GUIDELINE (GL) RECOMMENDATIONS, AND EVIDENCE FOR PATIENTS WITH ADVANCED NON SMALL CELL LUNG CANCER (NSCLC): AN ANALYSIS FROM THE NCCN ONCOLOGY OUTCOMES DATABASE by Lepisto, E.M, Vandergrift, J.L, Kalemkerian, G.P, Pisters, K.M, Zornosa, C, Rabin, M.S, Reid, M.E, Koczywas, M, Otterson, G.A, Ettinger, D.S

Get full text

Can We Deliver High Dose Radiation in 6 Weeks with Concurrent Chemotherapy in Stage III Non-small Cell Lung Cancer? by Kong, F.P, Ten Haken, R.K, Hayman, J.A, Cease, K, Ramnath, N, Arenberg, D, Curtis, J, Orringer, M, Kalemkerian, G.P, Lawrence, T.S

Get full text

Genetic Variation in TGFβ1, tPA and ACE May Predict Radiation-induced Thoracic Toxicity in Patients with Non-small Cell Lung Cancer by Yuan, S, Ellingrod, V.L, Schipper, M, Stringer, K, Cai, X, Hayman, J.A, Ten Haken, R.K, Kalemkerian, G.P, Lawrence, T.S, Kong, F

Get full text

FDG-PET/CT during Radiation Therapy to Predict Survival and Guide Individualized Adaptive Dose Escalation in Patients with Non–small-cell Lung Cancer by Kong, F, Ten Haken, R.K, Gross, M, Frey, K.A, Hayman, J.A, Kalemkerian, G.P, Eisbruch, A, Lawrence, T.S

Get full text

The Additional Value of V/Q SPECT over Q SPECT Alone for Pulmonary Function Mapping before, during and after Radiotherapy in Patients with Non–small Cell Lung Cancer by Yuan, S, Frey, K.A, Gross, M.D, Hayman, J.A, Ramnath, N, Arenberg, D, Curtis, J, Ten Haken, R.K, Kalemkerian, G.P, Kong, F

Get full text

Safety and efficacy of pralsetinib in RET fusion–positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trial by Griesinger, F., Curigliano, G., Thomas, M., Subbiah, V., Baik, C.S., Tan, D.S.W., Lee, D.H., Misch, D., Garralda, E., Kim, D.-W., van der Wekken, A.J., Gainor, J.F., Paz-Ares, L., Liu, S.V., Kalemkerian, G.P., Houvras, Y., Bowles, D.W., Mansfield, A.S., Lin, J.J., Smoljanovic, V., Rahman, A., Kong, S., Zalutskaya, A., Louie-Gao, M., Boral, A.L., Mazières, J.

“…RET fusions are present in 1%-2% of non-small-cell lung cancer (NSCLC). Pralsetinib, a highly potent, oral, central nervous system-penetrant, selective RET…”
Get full text

Interplay of Cardiac and Pulmonary Toxicity: An Analysis of Prospective Trials for Locally Advanced Non-Small Cell Lung Cancer by Dess, R.T., Sun, Y., Matuszak, M.M., Sun, G., Schonewolf, C.A., Kong, F.M., Gadgeel, S.M., Kalemkerian, G.P., Hayman, J.A., Haken, R. K. Ten, Lawrence, T.S., Schipper, M., Jolly, S.

Get full text

1782MO Health-related quality of life (HRQoL) in KEYNOTE-604: Pembrolizumab (pembro) or placebo added to etoposide and platinum (EP) as first-line therapy for ES-SCLC by Kim, H.R., Awad, M.M., Navarro, A., Gottfried, M., Peters, S., Csőszi, T., Cheema, P.K., Rodriguez-Abreu, D., Wollner, M., Yang, J.C-H., Mazieres, J., Orlandi, F.J., Luft, A., Gümüş, M., Kato, T., Kalemkerian, G.P., Luo, Y., Santorelli, M.L., Pietanza, M.C., Rudin, C.M.

Get full text

Esophageal Dose, Clinical Factors, and Cytokines: Predicting Radiation-Induced Esophagitis in Non–small Cell Lung Cancer by Hawkins, P.G., Boonstra, P.S., Hobson, S., Hearn, J.W.D., Hayman, J.A., Haken, R.K. Ten, Matuszak, M.M., Stanton, P., Kalemkerian, G.P., Lawrence, T.S., Schipper, M., Kong, F.M., Jolly, S.

Get full text

Circulating microRNAs as Biomarkers of Radiation-Induced Cardiac Toxicity in Non-Small Cell Lung Cancer by Hawkins, P.G., Sun, Y., Dess, R.T., Jackson, W.C., Sun, G., Bi, N., Tewari, M., Hayman, J.A., Kalemkerian, G.P., Lawrence, T.S., Haken, R.K. Ten, Matuszak, M.M., Kong, F.M., Schipper, M., Jolly, S.

Get full text

Pretreatment CT Based Emphysema and Fibrosis Scoring of Peri-Tumoral Lung Parenchyma Predicts Risk of Radiation Induced Lung Toxicity by Jackson, W.C., Boonstra, P.S., Hawkins, P.G., Owen, D.R., Jain, P., Sun, G., Arenberg, D., Lee, E., Kalemkerian, G.P., Kong, F.M., Hayman, J.A., Lawrence, T.S., Ten Haken, R.K., Schipper, M., Matuszak, M.M., Jolly, S.

Get full text

Cardiac Events and Definitive Radiation Therapy for Locally Advanced Non–small Cell Lung Cancer: A Focus on Patients Without Baseline Coronary Artery Disease by Dess, R.T., Sun, Y., Matuszak, M.M., Sun, G., Soni, P.D., Bazzi, L., Murthy, V.L., Hearn, J.W.D., Kong, F.M., Kalemkerian, G.P., Hayman, J.A., Haken, R. K. Ten, Lawrence, T.S., Schipper, M., Jolly, S.

Get full text